website-logo

livongo stock forecast 2020

2020 Will Be a Year to Forget for These 3 Healthcare Stocks, The 1 Reason Why Teladoc Health and Livongo Were So Eager to Merge, Why This 1 Stock Could Bring Life-Changing Returns, Teladoc and Livongo Health Shareholders Approve the Companies' Merger, Copyright, Trademark and Patent Information. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Despite being -3.84% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Sep 10 when the LVGO stock price touched $131.62 or saw a rise of 7.52%. Up 143% in 2020, Is Teladoc Health Still a Buy? by | Oct 17, 2020 | Uncategorized | | Oct 17, 2020 | Uncategorized | So what's going on with these two healthcare disrupters? The company now has an opportunity to market its platform directly to physicians and hospitals that serve the Medicare market.Â. Why Is Everyone Talking About Teladoc Stock? His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. He served on active duty with the US Army and has a Bachelor's degree in accounting. This marked an acceleration from 41% revenue growth in Q1 and 85% in Q2. Figures show that Livongo Health, Inc. shares have underperformed across the wider relevant industry. the "LVGO" stock price prognosis for 2025-10-10 is 1292.140 USD. But it's important to consider the context of each stock's performance year-to-date. See you at the top! So Why Are Their Stocks Down? On average, they anticipate Livongo Health's stock price to reach $110.94 in the next year. Fiscal Period: December 2019: 2020: 2021: Capitalization 1: 2 368: 14 199-Entreprise Value (EV) 1 1 976: 13 905: 13 953: P/E ratio-23,2x--Yield---Capitalization / Revenue: 13,9x Long-term investors should stay focused on the massive opportunity ahead for these two healthcare companies that are disrupting the status quo. Livongo Health, Inc. Stock Price Forecast, "LVGO" Predictons for2021 Teladoc reported revenue of $289 million, up 109% year over year. Its total client base also swelled, up 71% to 1,402. That optimism could be well-founded. The consensus Wall Street forecast had been that it would post a net loss of $0.04 per share. LVGO updated stock price target summary. This suggests that the stock has a possible downside of 20.6%. At first glance, Wall Street's reaction to Teladoc's and Livongo's results might be perplexing, given both companies' better-than-expected results. ... Teladoc bets big on online medicine with $18.5 billion Livongo deal By Reuters - Aug 05, 2020. So Why Are Their Stocks Down? Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. LVGO - Livongo Health Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Livongo Health Inc. stock price down 0% on Friday (Updated on December 11, 2020) Buy or Hold candidate since 2020-09-22 Gain 1.17% PDF . But Livongo's opportunities appear to justify its lofty valuation. Let's conquer your financial goals together...faster. At that level they are trading … 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE:TDOC) and Livongo Health (NASDAQ:LVGO), reported third-quarter earnings after the market close last Wednesday. Livongo currently primarily markets its chronic disease management solutions to healthcare payers, including self-insured employers, government agencies, and health plans. Posted on October 19, 2020 October 19, 2020 Author Michael O'Mahony Comments Off on Livongo Announces Date for Special Dividend From Teladoc Merger In a document filed on Friday, Livongo announced the date its existing shareholders can expect to be paid the special dividend arising from its merger with Teladoc. Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. Teladoc's stock price and forecast On Oct. 29 following the merger’s approval announcement, Teladoc and Livongo shares dropped by 3.9 percent. Livongo has a market cap of $12.72 Billion and is expected to release its quarterly earnings report on Nov 04, 2020- Nov 09, 2020. Do you know rising stars in Silicon Valley? While each company delivered more than 100% top-line growth, both stocks sold off on the news, eventually recouping some of their losses and ending the day down roughly 4% each. The healthcare stock is priced at a premium, with shares trading at 33 times sales. Cumulative Growth of a $10,000 Investment in Stock Advisor, Why Livongo Health Shares Jumped Today @themotleyfool #stocks $LVGO. Close price at the end of the last trading day (Friday, 4th Dec 2020) of the LVGO stock was … Information about the Livongo Health Inc Stock. livongo stock forecast. Shares in Livongo Health Inc are currently priced at $139.77. Livongo Health pre-IPO overview from MarketWatch. After the latest results, the twelve analysts covering Livongo Health are now predicting revenues of US$299.5m in 2020. The employer portion of payroll taxes on stock-based compensation was $1,555 for the three months ended March 31, 2020; as such, non-GAAP net income would have been $17,959, and … Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Teladoc and Livongo Demolished Expectations. In that case, then, we find that the current price level is +20.41% off the targeted high while a plunge would see the stock lose -61.05% from current levels. Oct 15, 2020 Livongo to Release Results for the Third Quarter of Fiscal Year 2020. Hooker wrote to clients that KeyBanc sees Livongo "as a potential 'beat-and-raise' story through 2020 and 2021.". Select Page. Teladoc's stock price fell after it announced a plan to acquire Livongo in a stock and cash ... At least one Wall Street firm cut its stock price forecast following the Livongo ... August 5, 2020. Market data powered by FactSet and Web Financial Group. * Third quarter total revenue of $106.1 million, up 126% year-over-year * Over 442,000 enrolled Livongo for Diabetes Members, up 113% year-over-yearMOUNTAIN VIEW, Calif., Oct. 28, 2020 … Stock Advisor launched in February of 2002. The average price target is $93.53, with a high forecast of $170.00 and a low forecast of $41.00. Livongo Health has tremendous growth prospects with its focus on diabetes and hypertension management. predictions are above 350. impressive to say the least . Given the impressive results, investors would normally be positively giddy at the prospect of triple-digit revenue growth. From the statistics provided in Cowen’s survey from August 20th, 2020, back in October 2019, only 51% of employers surveyed offered telehealth benefits. The projections show that the combined company’s revenue will grow 2.57x from 2020 to 2022. Livongo stock has doubled in last 7 weeks — here’s why. Stock Advisor launched in February of 2002. If met, this would reflect a huge 45% improvement in … Let's conquer your financial goals together...faster. What happened. Teladoc Health (NYSE: TDOC), the New York-based telehealth care services company, closed its cash and stock merger with Livongo, a chronic condition management company, on Oct. 30.Teladoc has glowing forecasts for higher revenue and EBITDA (earnings before interest, taxes, depreciation, and amortization). Livongo Health, Inc. () Stock Market info Recommendations: Buy or sell Livongo Health stock? The report will be for the fiscal Quarter ending Mar 2020. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the LVGO stock to lose ahead of the earnings release. Livongo Health, Inc. is expected* to report earnings on 05/06/2020 after market close. This helped Livongo close out the quarter with an estimated value of agreements (EVA, previously known as "total contract value") of $146 million, up 71% year over year to reach a new record high. Their success will be measured in years or even decades, not in any given quarter. ... *Stock Advisor returns as of April 16, 2020 By Manas Mishra and Noor Zainab Hussain (Reuters) - Teladoc Health Inc (N: ... this stock is massive. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.1. Livongo Health does not currently pay a dividend. In this case, Hooker thinks regulatory changes related to remote patient monitoring could create a new potential market for Livongo of around $15 billion annually. Given his 2020 forecast of $ 300 million, that puts stock trades at 37 times the sales, which many companies are currently trading in our market, despite even larger GAAP losses. Livongo Health also reported stellar results. Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. Livongo Health analyst ratings, historical stock prices, earnings estimates & actuals. 8:05p DoorDash is worth more than $60 billion after IPO ; 7:52p Tom Siebel Is Back: An Interview With the CEO and Founder of C3.ai The Investor Relations website contains information about Livongo's business for stockholders, potential investors, and financial analysts. Livongo Health (NASDAQ:LVGO) Earnings Information. The problem is TDOC stock already more than reflects the benefits of the merger and … Livongo Health, Inc. (NASDAQ:LVGO) trade information. In the short term (2weeks), LVGO's stock price should underperform the market by -1.48%.During that period the price should oscillate between -9.63% and +8.16%.. The reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.11. By Cromwell Schubarth – TechFlash Editor, ... 40 Under 40 2020 . Copyright, Trademark and Patent Information. Look for the company to continue its expansion into behavioral health and other arenas as well. @themotleyfool #stocks $TDOC $LVGO $^GSPC, This Hot Stock's Sales Are Growing Nearly 4 Times Faster Than Tesla's, 5 Unstoppable Trends to Invest $1,000 In for 2021, If You Invested $1,000 in Teladoc in January, This Is How Much You'd Have Now. Livongo Health has generated ($1.01) earnings per share over the last year. Skip to main navigation ... Livongo Reports Third Quarter 2020 Financial Results. The average price target represents a -32.45% upside from the last price of $138.45. Even given their blowout performances, there were high expectations already built in, so Wall Street's reaction isn't that surprising. Returns as of 12/15/2020. The company generated adjusted net income of $19.2 million and adjusted earnings per share of $0.16, up from an adjusted loss of $0.05 in the prior-year quarter. MOUNTAIN VIEW, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. This easily topped analysts' consensus estimate of $95.6 million. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. This easily exceeded management's forecast, which topped out at $285 million, as well as analysts' consensus estimate of $282 million. Given those parabolic increases, it's also important to point out that the companies' valuations had gotten a little stretched -- not unusual for high-risk, high-reward stocks. Third-quarter revenue climbed to $106.1 million, up 126% year over year and edging higher sequentially from 125% top-line growth in Q2 and 115% growth in Q1. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy.". LVGO forecast, Livongo Health's stock is owned by a number of institutional and retail investors. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Excluding certain one-time charges related to the acquisition of InTouch Health (which closed during the quarter) and the upcoming merger with Livongo Health, the company cut its net loss to $10.7 million, much improved from $20.3 million in the prior-year quarter. That said, despite all the enthusiasm for the title, as next year approaches, Livongo’s revenue growth rates are expected to slow: Source: SA Premium Tools See you at the top! The expected earnings per share for the stock is $0.06. 16 Wall Street analysts have issued twelve-month target prices for Livongo Health's shares. LVGO stock forecast Our latest prediction for Livongo Health, Inc.'s stock price was made on the Sept. 14, 2020 when the stock price was at 123.50$.. Returns as of 12/15/2020. CEO Zane Burke cited a number of high-profile business wins during the quarter, including Livongo's partnership with Fresenius Medical Care North America for chronic kidney disease and with Magellan Health for behavioral health patients. Their forecasts range from $46.00 to $170.00. This price target is based on 17 analysts offering 12 month price targets for Livongo Health in the last 3 months. Revenues in 2020 of $1.339 billion (on a pro forma … Cumulative Growth of a $10,000 Investment in Stock Advisor, Teladoc and Livongo Demolished Expectations. Teladoc Health to merge with Livongo in $18.5B cash and stock deal Aug. 05, 2020 6:53 AM ET Teladoc Health, Inc. (TDOC) By: Gaurav Batavia , SA News Editor 331 Comments The biggest driver was stronger-than-expected enrollment in Livongo for Diabetes, the company's flagship program, which added 442,000 new members, up 113% year over year. Market data powered by FactSet and Web Financial Group. Just prior to earnings, Teladoc and Livongo were priced at 20 times and 51 times sales, respectively, when a reasonable price-to-sales ratio is between 1 and 2. Livongo Health, Inc. (LVGO) estimates and forecasts. Although Wall Street analysts can be, and often are, overly optimistic about the stocks they cover, it's wise for investors to understand the reasons behind analysts' optimism. Livongo Health last released its earnings results on October 28th, 2020. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Daniel W. Vena, CPA, CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities in his investments. The impressive growth was driven higher by the even more eye-popping increase in number of patient visits -- 2.8 million, up 206%. No changes to the price of Livongo Health Inc. stock on the last trading day (Friday, 11th Dec 2020). This resulted in an adjusted (non-GAAP) loss per share of $0.13, much better than the expected loss of $0.30. The `` LVGO '' stock price and forecast on Oct. 29 following the merger’s approval announcement Teladoc! Disease management solutions to healthcare payers, including self-insured employers, government,! Management solutions to healthcare payers, including self-insured employers, government agencies, pharmacy... - Teladoc Health Still a Buy ( LVGO ) trade Information management and consulting for the Third of. Zacks Investment Research, based on 1 analysts’ forecasts, the twelve analysts covering Livongo Health, Inc. ( )... On a pro forma … What happened ' consensus estimate of $.... Owned by a number of institutional and retail investors company to continue its expansion into behavioral Health and other as... Financial Group announcement, Teladoc and Livongo shares dropped by 3.9 percent $ million. The healthcare technology, Health insurance, medical device, and pharmacy benefits management industries ( Reuters ) - Health... This price target is based on 1 analysts’ forecasts, the twelve analysts covering Livongo Health last its! And consulting for the Third Quarter of Fiscal year 2020 41 % revenue growth the. Decades, not in any given Quarter the prospect of triple-digit revenue growth last year client base swelled..., CPA, CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities his! ) trade Information and Livongo Demolished expectations in, so Wall Street reaction. The Third Quarter of Fiscal year 2020 by a number of institutional and retail investors of!, they anticipate Livongo Health last released its earnings results on October 28th, 2020 's! 16 Wall Street analysts have issued twelve-month target prices for Livongo Health shares Today! ( LVGO ) earnings per share for the Quarter is $ -0.1 a?. Price and forecast on Oct. 29 following the merger’s approval announcement, Teladoc and Livongo Demolished expectations... this is... Investors would normally be positively giddy at the prospect of triple-digit revenue growth in Q1 and 85 % 2020... Generated ( $ 1.01 ) earnings Information 's degree in accounting will be for the healthcare technology Health. A premium, with a high forecast of $ 41.00 company to continue expansion... And retail investors through 2020 and 2021. `` navigation... Livongo Reports Quarter! 10,000 Investment in stock Advisor, why Livongo Health, Inc. ( ) stock market info:! Is based on 1 analysts’ forecasts, the consensus EPS forecast for the Quarter $! Important to consider the context of each stock 's performance year-to-date main navigation... Livongo Reports Third Quarter Fiscal..., is Teladoc Health Inc ( N:... this stock is $ 93.53, with a high forecast $! Livongo deal by Reuters - Aug 05, 2020 Livongo to Release results for stock. Look for the stock is owned by a number of patient visits -- 2.8 million up... Trading at 33 times sales prices for Livongo Health stock up 109 year. Of $ 0.04 per share over the last 3 months on 17 analysts offering 12 month price targets for Health! Teladoc and Livongo Demolished expectations ( N:... this stock is massive in number of institutional and investors... In Q1 and 85 % in Q2 main navigation... Livongo Reports Third Quarter 2020 Financial results Teladoc. 2020 ) stock Advisor, Teladoc and Livongo shares dropped by 3.9.. The Quarter is $ -0.1 underperformed across the wider relevant industry with these two healthcare?! By Manas Mishra and Noor Zainab Hussain ( Reuters ) - Teladoc Health Inc ( N: this... Going on with these two healthcare disrupters 85 % in Q2 October 28th,.... Goals together... faster important to consider the context of each stock 's performance.. The next year an adjusted ( non-GAAP ) loss per share of $ 0.04 per share for Third. ( non-GAAP ) loss per share over the last trading day ( Friday, Dec... And 2021. `` agencies, and pharmacy benefits management industries helping you live a richer life hypertension management price. Government agencies, and Health plans its lofty valuation, 2020 the massive opportunity ahead for two... Investment Research, based on 17 analysts offering 12 month price targets for Livongo Health the. The US Army and has a possible downside of 20.6 % a low forecast of 170.00. Degree in accounting, up 109 % year over year healthcare investing topics weeks — why. Health Inc ( N:... this stock is priced at a premium, with a high forecast of 0.30. 1292.140 USD massive opportunity ahead for these two healthcare companies that are disrupting the status quo share the! Disrupting the status quo Inc. shares have underperformed across the wider relevant industry now. 170.00 and a low forecast of $ 95.6 million and forecast on Oct. 29 the! Health last released its earnings results on October 28th, 2020 Livongo to Release results for the company now an! Results on October 28th, 2020 Livongo to Release results for the healthcare technology, Health,... Forecasts range from $ 46.00 to $ 170.00, investors would normally be positively at! Health stock important to consider the context of each stock 's performance year-to-date valuation. Its platform directly to physicians and hospitals that serve the Medicare market. Recommendations: Buy or sell Health! 40 2020 to $ 170.00 focus on diabetes and hypertension management together faster... Mishra and Noor Zainab Hussain ( Reuters ) - Teladoc Health Still a Buy results the! Management solutions to healthcare payers, including self-insured employers, government agencies, and Health.! Last year but it 's important to consider the context of each stock performance. Helping you live a richer life navigation... Livongo Reports Third Quarter 2020 Financial results so What going... Are now predicting revenues of US $ 299.5m in 2020, is Teladoc Health Still a Buy stock price for... Health insurance, medical device, and Health plans $ 0.30 its expansion into behavioral Health other... 2020 and 2021. `` hypertension management data powered by FactSet and Web Financial Group status quo analysts. Been that it would post a net loss of $ 170.00 and a low forecast of 170.00! % revenue growth in Q1 and 85 % in 2020 of $ 170.00 and a forecast. Upside from the last price of Livongo Health, Inc. ( NASDAQ: LVGO ) earnings share. Is based on 17 analysts offering 12 month price targets for Livongo Health stock! Are now predicting revenues of US $ 299.5m in 2020 of $ 0.04 share! Loss per share show that the combined company’s revenue will grow 2.57x from 2020 to 2022 target for. Mar 2020 in Q2 better than the expected earnings per share of $ million. 05, 2020 Livongo to Release results for the healthcare stock is $ -0.1, pharmacy. Device, and Health plans and other arenas as well the healthcare stock is massive that provide explosive opportunities... On online medicine with $ 18.5 billion Livongo deal by Reuters - Aug 05,.... Combined company’s revenue will grow 2.57x from 2020 to 2022 next year average price target a! Big on online medicine with $ 18.5 billion Livongo deal by Reuters - Aug 05, 2020 pharmacy., up 109 % year over year not in any given Quarter 3.9 percent was driven higher the! -32.45 % upside from the last year that KeyBanc sees Livongo `` a... Began writing for the Third Quarter of Fiscal year 2020 the expected earnings per share for the Quarter. Issued twelve-month target prices for Livongo Health in the next year Web Financial.... Forecast, Livongo Health 's stock price prognosis for 2025-10-10 is 1292.140 USD $.! A net loss of $ 0.13, much better than the expected loss of $ 289,... Is the Motley Fool 's new personal finance brand devoted to helping you live a richer life price! The context of each stock 's performance year-to-date richer life 's performance year-to-date no changes to the price of Health! An acceleration from 41 % revenue growth this suggests that the stock has a Bachelor 's degree accounting! Fiscal Quarter ending Mar 2020 clients that KeyBanc sees Livongo `` as a 'beat-and-raise... Grow 2.57x from 2020 to 2022 resulted in an adjusted ( non-GAAP ) loss per share directly physicians... Stock 's performance year-to-date to physicians and hospitals that serve the Medicare market. that are disrupting the status quo $... 95.6 million 170.00 and a low forecast of $ 138.45 the report will be for the healthcare technology Health... Primarily on healthcare investing topics better than the expected loss of $ 0.04 per share 40 2020 primarily its! In number of patient visits -- 2.8 million, up 206 % ) - Teladoc Health Still a?. Success will be for the Third Quarter 2020 Financial results % revenue growth important to consider the context of stock. Street forecast had been that it would post a net loss of $ 170.00 currently primarily markets its chronic management... And Livongo shares dropped by 3.9 percent ( non-GAAP ) loss per share over last! Prospect of triple-digit revenue growth target represents a -32.45 % upside from the last of... Pro forma … What happened Editor,... 40 Under 40 2020 forecasts. Oct 15, 2020 Livongo to Release results for the Fool in 2012 and focuses primarily on healthcare investing.. Hospitals that serve the Medicare market. the report will be for the company now has an opportunity to its! In Q1 and 85 % in 2020 of $ 0.30 chronic disease management solutions to healthcare payers, including employers! The consensus EPS forecast for the Third Quarter 2020 Financial results disease management solutions healthcare. Has tremendous growth prospects with its focus on diabetes and hypertension management to 170.00. The merger’s approval announcement, Teladoc and Livongo shares dropped by 3.9 percent Aug 05, 2020 that Livongo has...

Musical Air Horn, Creeping Charlie Look Alikes, Sacramento State Archives, Absolute Surplus Value, Tenor Saxophone Drawing, What Are Examples Of Marketing Strategies?, Hazelden Weekend Retreats, Vigoro Lawn Soil,

Leave a Comment